Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Suven Pharmaceuticals Ltd
Suven Pharmaceuticals Ltd

Suven Pharmaceuticals Ltd (SUVENPHAR) Share Price

  • Sector: Pharmaceuticals (Mid Cap)
  • Volume: 3,03,345
Dec 05, 2025
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹542.55
₹-6.55 (-1.19%)
533.55Low
Today’s Performance
548.90High
533.55Low
52 Week’s Performance
1,342.00High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-1.19%
  • 1 Week-3.87%
  • 1 Month-25.05%
  • 3 Months-41.21%
  • 6 Months-48.99%
  • 1 Year-58.14%
  • 3 Years5.42%
  • 5 Years6.42%

bt_logoStock Summary

  • Face Value (₹)1.00
  • Beta0.61
  • 52-Week Low (₹)533.55
  • 52-Week High (₹)1,342.00
  • Price-to-Book (X)*5.55
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*67.05
  • Earnings Per Share (₹)8.19
  • Market Cap (₹ Cr.)*21,006.76
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations7:17Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations
FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support5:04FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support
India–Russia Trade to Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership2:31India–Russia Trade To Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership
Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push11:22Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push
IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide3:48IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide
India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities2:42India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities
Passengers Angry Over IndiGo Delays, Complain Of No Information3:16Passengers Angry Over IndiGo Delays, Complain Of No Information
Vikram Misri: India–Russia to Accelerate FTA, Investment Treaty and Key Connectivity Negotiations1:58Vikram Misri: India–Russia To Accelerate FTA, Investment Treaty And Key Connectivity Negotiations
‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War3:01‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War
IndiGo Flight Chaos: Delhi Airport Meltdown, DGCA Relaxes Crew Rostering Restrictions8:35IndiGo Flight Chaos: Delhi Airport Meltdown, DGCA Relaxes Crew Rostering Restrictions
View more

bt_logoFAQ's

What was Suven Pharmaceuticals Ltd share price previously?
Suven Pharmaceuticals Ltd share price was down by -1.19% from the previous closing price of ₹549.10.
Who are peers of Suven Pharmaceuticals Ltd?
The peers of Suven Pharmaceuticals Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Suven Pharmaceuticals Ltd?
The promotor/promotors of Suven Pharmaceuticals Ltd are Vivek Sharma, Vinod Padikkal, K G Ananthakrishnan, Matangi Gowrishankar, Vinod Rao, U B Pravin Rao, Jaishankar Krishnan, Pankaj Patwari, Shweta Jalan, KUNDAN KUMAR JHA, Himanshu Agarwal.
What has been 52-week high of Suven Pharmaceuticals Ltd stocks?
The highest price of Suven Pharmaceuticals Ltd stock is ₹1,342.00 in the last 52-week.
What is the share price of Suven Pharmaceuticals Ltd (COHANCE) today on NSE?
As on Dec 05, 2025 Suven Pharmaceuticals Ltd (COHANCE)’s share price on NSE is Rs 542.55
What is the market cap of Suven Pharmaceuticals Ltd (COHANCE)?
The current market capitalisation of Suven Pharmaceuticals Ltd (COHANCE) is 21,006.76 crores
What is Suven Pharmaceuticals Ltd Share symbol?
The symbol of Suven Pharmaceuticals Ltd is COHANCE.
What is the PE ratio of Suven Pharmaceuticals Ltd (COHANCE)?
The current PE ratio of Suven Pharmaceuticals Ltd (COHANCE) is 67.05.
What is the PB ratio of Suven Pharmaceuticals Ltd (COHANCE)?
The current PB ratio of Suven Pharmaceuticals Ltd (COHANCE) is 5.55.
Today’s High & Low share prices of Suven Pharmaceuticals Ltd (COHANCE) on NSE?
Today, the share price of Suven Pharmaceuticals Ltd (COHANCE) on NSE touched a high of Rs 548.9 and a low of Rs 533.55
What price did Suven Pharmaceuticals Ltd (COHANCE) shares open on the NSE today?
On NSE, the share price of Suven Pharmaceuticals Ltd (COHANCE) opened at Rs 546.5
What is the 52-week high of Suven Pharmaceuticals Ltd (COHANCE)?
The 52-week high price of Suven Pharmaceuticals Ltd (COHANCE) is Rs 1,342.00
What is the 52-week low of Suven Pharmaceuticals Ltd (COHANCE)?
The 52-week low price of Suven Pharmaceuticals Ltd (COHANCE) is Rs 533.55

bt_logoAbout Suven Pharma

Cohance Lifesciences Ltd, incorporated in the year 2018, has its registered office in 8-2-334 SDE Serene Chambers, 3 Floor Avenue 7 Road No 5, Hyderabad, Telangana, 500034, 91-40-23549414/1142/3311, 91-40-23541152. The main industry in which Cohance Lifesciences Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Cohance Lifesciences Ltd is/are Karvy & Co/Walker Chandiok & Co LLP. In the main management, Vivek Sharma is chairman and is the company secretary for Cohance Lifesciences Ltd.

  • VS
    Vivek SharmaChairman & Exec. Director
  • VP
    Vinod PadikkalNon-Exec & Non-Independent Dir
  • KGA
    K G AnanthakrishnanIndependent Non Exe. Director
  • MG
    Matangi GowrishankarIndependent Non Exe. Director
  • VR
    Vinod RaoIndependent Non Exe. Director
  • UBPR
    U B Pravin RaoIndependent Non Exe. Director
  • JK
    Jaishankar KrishnanIndependent Non Exe. Director
  • PP
    Pankaj PatwariNon Executive Director
  • SJ
    Shweta JalanNon Executive Director
  • KKJ
    KUNDAN KUMAR JHACS / Compliance Officer / Legal Head
  • HA
    Himanshu AgarwalWhole Time Director & Chief Financial Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.